EponaCell is a research based biotech company focusing on treating damage to the musculoskeletal systems of horses and dogs using advanced cell therapy products.
The company has been on the market since 2010 and currently prides itself on references of successfully treated patients on file. EponaCell prepares its certified products using the appropriate manufacturing practice and authorisation for manufacturing cell treatment products, while at the same time is strongly committed to researching and developing new cell therapies and other health products.
EponaCell offers economical and effective treatment to animal patients with cartilage problems - osteoarthritis and osteochondrosis, injuries to tendons and ligaments.
Cell therapy involves the application of autologous (own) mesenchymal stem cells isolated from the bone marrow directly onto the affected site. The treatment is targeted which means other tissues and organs in the body are left intact.
Treatment of bone marrow and the production of cellular products takes place in a monitored sterile environment using the highest quality materials to ensure the product is safe and effective. The actual procedure is fast, patient-friendly and does not require a long period of convalescence.
The patient arrived at the clinic diagnosed with ataxia to the hind limb and dysplasia to the right hip joint. Although the patient was suffering from a neurological disorder in conjunction with orthopaedic disease and the prognosis wasn’t clear, the owner still wanted to go ahead with cellular therapy. Following the application of stem cells, the patient’s condition improved and he has even returned to retrieving and has a desire to run.
Two-year old Border Collie bitch was brought to the clinic. During a clinical examination she was found to have a stage 2 limp on both hind legs, a short step, soreness in both hip joints and hypertrophy of the left knee joint with mild pain. The knee joint was diagnosed with an osteochondral lesion with a calcified loose fragment.